Expression of Opioid Receptors in Osteoblast-Like MG-63 Cells, and Effects of Different Opioid Agonists on Alkaline Phosphatase and Osteocalcin Secretion by These Cells
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We have previously shown that several stressful situations associated with tissue injury determine a decrease in serum osteocalcin concentration. Since reduced osteocalcin production is a marker of decreased osteoblastic activity, this finding could be related to the pathogenesis of osteoporosis secondary to some diseases. Endogenous opioids are involved in stress response. Proenkephalin-derived peptides have been shown to inhibit alkaline phosphatase activity, another marker of bone formation, in the murine cell line ROS-17/2.8. On the other hand, serum osteocalcin has been reported as being low in heroin abusers. We have therefore thought it of interest to study the presence of opioid receptors in the human osteoblast-like cell line MG-63, and to evaluate the effects of different opioid agonists on the secretion of alkaline phosphatase and osteocalcin by these cells. The presence of opioid receptors was studied by means of RT-PCR and immunohistochemistry. RT-PCR studies suggested the presence of specific mRNA for the three types of receptors, and immunohistochemistry clearly showed their occurrence. Osteocalcin synthesis was significantly inhibited by high concentrations of the mu agonists morphine and (D-Ala 2,N-MePhe 4,Gly 5-ol)-enkephalin although no changes were seen with the delta agonist (D-Ala 2,D-leu 5)-enkephalin. Morphine-induced osteocalcin inhibition was abolished when osteoblastic cells were incubated simultaneously with naloxone, whereas it was potentiated when cells were preincubated with naloxone. None of the opioid agonists modified the secretion of alkaline phosphatase. In conclusion, human osteoblast-like cells MG-63 express the three types of opioid receptors. Endogenous opioids may be involved in the reduction of osteocalcin observed in stressful situations associated with tissue injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pivotal experiments from two decades ago confirmed the expression of three types of opioid receptors, namely MOR, delta-opioid receptors, and kappa-opioid receptors in the human osteoblast-like cell line MG-63 via reverse transcription-polymerase chain reaction and immunohistochemistry (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“Data deriving from in vitro experiments on animal and human cells, as well as in animal models indicate that opioids can reduce BMD by directly influencing osteoblast activity (205-210).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“Treatment with high concentrations of the MOR agonist morphine significantly inhibited the expression of osteocalcin, a marker of osteoblast activity, without influencing the secretion of alkaline phosphatase (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“In addition, treatment with the opioid antagonist naloxone reversed the effect of morphine with regards to osteocalcin expression (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Stress hormones: their interaction and regulation
Axelrod, J., & Reisine, T. D. (1984) · Science · doi:10.1126/science.6143403 · Cited by 1,527
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Endogenous Opioids: Biology and Function
Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., & Walker, J. M. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001255 · Cited by 1,224
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., & Bell, G. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6736 · Cited by 618
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 359
Research works printed but not linked: 1
- 10.1006/abio.1987.9999 · doi:10.1006/abio.1987.9999 · Paper page
Cited by
Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury
Hsu, J. R., Mir, H., Wally, M. K., Seymour, R. B., & the Orthopaedic Trauma Association Musculoskeletal Pain Task Force (2019) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001430 · Cited by 280
Bone mineral density in subjects using central nervous system-active medications
Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.033 · Cited by 191
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 166
Low bone density in patients receiving methadone maintenance treatment
Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.027 · Cited by 131
Vaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 88
Böhm, M., & Grässel, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1016 · Cited by 79
Coluzzi, F., Mattia, C., Raffa, R. R., & Pergolizzi, J. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s79409 · Cited by 77
“When incubated with morphine, osteocalcin synthesis is significantly reduced, while alkaline phosphatase secretion is not affected, and naloxone completely reverses the effect of morphine on these cells.(27) Similarly, there are low serum osteocalcin levels in heroin- and cocaine-abusing women when pregnant, as well a…”
BackgroundOpioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection
Sharma, A., Flom, P. L., Weedon, J., & Klein, R. S. (2010) · AIDS · doi:10.1097/qad.0b013e32833d7da7 · Cited by 75
Decreased bone density in men on methadone maintenance therapy
Grey, A., Rix‐Trott, K., Horne, A., Gamble, G., Bolland, M., & Reid, I. R. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03159.x · Cited by 61
The effect of opiates on bone formation and bone healing
Coluzzi, F., Scerpa, M. S., & Centanni, M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00585-4 · Cited by 55
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain
Forte, B. L., Slosky, L. M., Zhang, H., Arnold, M. R., Staatz, W. D., Hay, M., Largent‐Milnes, T. M., & Vanderah, T. W. (2016) · Pain · doi:10.1097/j.pain.0000000000000690 · Cited by 53
Rehabilitation pharmacotherapy: A scoping review
Kose, E., & Wakabayashi, H. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13975 · Cited by 51
Understanding osteoporotic pain and its pharmacological treatment
Vellucci, R., Terenzi, R., Kanis, J. A., Kress, H. G., Mediati, R. D., Reginster, J., Rizzoli, R., & Brandi, M. L. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4476-y · Cited by 50
The association of opioid use with incident lower extremity fractures in spinal cord injury
Carbone, L. D., Chin, A. S., Lee, T. A., Burns, S. P., Svircev, J. N., Hoenig, H. M., Akhigbe, T., & Weaver, F. M. (2013) · The Journal of Spinal Cord Medicine · doi:10.1179/2045772312y.0000000060 · Cited by 46
Zhang, H., Lund, D. M., Ciccone, H. A., Staatz, W. D., Ibrahim, M. M., Largent‐Milnes, T. M., Seltzman, H. H., Spigelman, I., & Vanderah, T. W. (2018) · Pain · doi:10.1097/j.pain.0000000000001278 · Cited by 46
Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review
O’Rourke, T. K., & Wosnitzer, M. S. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0634-y · Cited by 45
Valverde-Filho, J., Cunha Neto, M. B. C. D., Fonoff, E. T., Meirelles, E. D. S., & Teixeira, M. J. (2015) · Pain Medicine · doi:10.1111/pme.12661 · Cited by 37
Demarest, S. P., Gill, R. S., & Adler, R. A. (2014) · Endocrine Practice · doi:10.4158/ep14339.ra · Cited by 35
Opioids delay healing of spinal fusion: a rabbit posterolateral lumbar fusion model
Jain, N., Himed, K., Toth, J. M., Briley, K. C., Phillips, F. M., & Khan, S. N. (2018) · The Spine Journal · doi:10.1016/j.spinee.2018.04.012 · Cited by 34
Opioid peptides and receptors in joint tissues: Study in the rat
Bergström, J. P., Ahmed, M., Li, J., Ahmad, T., Kreicbergs, A., & Spetea, M. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20132 · Cited by 33
Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity
Aslam, H., Ruusunen, A. A., Berk, M., Loughman, A., Rivera, L. R., Pasco, J. A., & Jacka, F. N. (2019) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2019.1614540 · Cited by 32
New opioid side effects and implications for long-term therapy
Raghavan, S., Harvey, A., & Humble, S. R. (2010) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.cacc.2010.06.003 · Cited by 31
Kinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Janas, A., & Folwarczna, J. (2017) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-016-1295-6 · Cited by 29
The role of opioid systems on orthodontic tooth movement in cholestatic rats.
Nilforoushan, D., Shirazi, M., & Dehpour, A. R. (2002) · PubMed · doi:10.1043/0003-3219(2002)072<0476:trooso>2.0.co;2 · Cited by 27
Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing
Cottrell, J. A., MEYENHOFER, M. F., Medicherla, S., Higgins, L. S., & O’Connor, P. J. (2009) · Pain · doi:10.1016/j.pain.2008.12.019 · Cited by 26
From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks
Jaschke, N., Pählig, S., Pan, Y., Hofbauer, L. C., Göbel, A., & Rachner, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.004 · Cited by 24
Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids
Vangala, C., Niu, J., Montez‐Rath, M. E., Yan, J., Navaneethan, S. D., Naik, A. D., & Winkelmayer, W. C. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019090904 · Cited by 24
Ding, Z., Chen, Y., Wang, X., zhou, X., Xu, Y., Ma, Z., Sun, Y., & Jiang, M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.010 · Cited by 23
Effects of prenatal cocaine, morphine, or both on postnatal opioid (μ) receptor development
Bhat, R., Chari, G., & Rao, R. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.023 · Cited by 23
Marczak, E. D., Jinsmaa, Y., Myers, P. H., Blankenship, T., Wilson, R., Balboni, G., Salvadori, S., & Lazarus, L. H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.041 · Cited by 22
“Considering that opioid receptors are expressed in bones and joints (Elhassan et al., 1998; Perez-Castrillon et al., 2000), and that opioid agonists inhibit growth of osteoblasts and osteocalcin production in cell cultures, it is sufficient to explain their effect on bone deterioration in vivo.”
Drug-induced osteoporosis: Beyond glucocorticoids
Briot, K., & Roux, C. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0019-4 · Cited by 22
Petrizzi, L., Mariscoli, M., Valbonetti, L., Varasano, V., Langhoff, J. D., & Von Rechenberg, B. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-43 · Cited by 21
Tanaka, K., Kondo, H., Hamamura, K., & Togari, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.069 · Cited by 21
Adesina, O., Gurney, J. G., Kang, G., Villavicencio, M., Hodges, J., Chemaitilly, W., Kaste, S. C., Zemel, B. S., & Hankins, J. S. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018026047 · Cited by 21
How Do Drugs Affect the Skeleton? Implications for Forensic Anthropology
Márquez‐Grant, N., Baldini, E., Jeynes, V., Biehler‐Gomez, L., Lebrahimi, L. A., Passalacqua, N. V., Giordano, G., Candia, D. D., & Cattaneo, C. (2022) · Biology · doi:10.3390/biology11040524 · Cited by 21
Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem
Buss, T., & Leppert, W. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0096-x · Cited by 20
Thakur, N. A., DeBoyace, S. D., & Margulies, B. S. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.23135 · Cited by 20
The effect of morphine on orthodontic tooth movement in rats
Akhoundi, M. S. A., Dehpour, A. R., Rashidpour, M., Alaeddini, M., Kharazifard, M. J., & Noroozi, H. (2010) · Australasian Orthodontic Journal · doi:10.2478/aoj-2010-0019 · Cited by 19
Emerging therapies in metastatic bone pain
Coluzzi, F., Mandatori, I., & Mattia, C. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.576668 · Cited by 19
Bone mineral density in young women on methadone substitution
Milos, G., Gallo, L. M., Sosic, B., Uebelhart, D., Goerres, G., Haeuselmann, H.-J., & Eich, D. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9510-4 · Cited by 18
“Some opioids seem also to compromise bone metabolism [10, 11, 13].”
BackgroundYoon, J.-Y., Baek, C.-W., Kim, H.-J., Kim, E.-J., Byeon, G.-J., & Yoon, J.-U. (2018) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-018-0116-z · Cited by 17
Opioid-induced androgen deficiency
Daniell, H. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224806.08824.dc · Cited by 17
Effect of Tramadol (μ-opioid receptor agonist) on orthodontic tooth movements in a rat model.
Rashidpour, M., Akhoundi, M. S. A., Nik, T. H., Ar, D., Alaeddini, M., Javadi, E., & Noroozi, H. (2012) · PubMed Central · Cited by 16
Effect of tramadol at different doses on orthodontic tooth movement and bone resorption in rats.
Aghili, H. A., Moghadam, M. G., Yassaei, S., Meybodi, A. R. F., & Tabatabaei, S. M. A. (2013) · PubMed Central · doi:10.4103/1735-3327.115152 · Cited by 16
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Effects of remifentanil preconditioning on osteoblasts under hypoxia-reoxygenation condition
Baik, S.-W., Park, B.-S., Kim, Y.-H., Kim, Y.-D., Kim, C.-H., Yoon, J.-Y., & Yoon, J.-U. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11839 · Cited by 14
Engineering endomorphin drugs: state of the art
Lazarus, L. H., & Okada, Y. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.646261 · Cited by 13
Association between opioid use disorder and fractures: a population‐based study
Hsu, W., Lin, C., & Kao, C. (2019) · Addiction · doi:10.1111/add.14732 · Cited by 13
Effects of maternal consumption of morphine on rat skeletal system development
Saeidinezhad, M., Razban, V., Safizadeh, H., & Ezzatabadipour, M. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04321-6 · Cited by 12
Crucial role of peripheral κ‐opioid receptors in a model of periodontal disease in rats
Pacheco, C. M. D. F., Queiroz‐Junior, C. M., Maltos, K. L. M., Caliari, M. V., Pacheco, D. F., Duarte, I. D. G., & Francischi, J. N. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01102.x · Cited by 12
Lambrechts, M. J., D’Antonio, N. D., Heard, J. C., Toci, G. R., Karamian, B. A., Sherman, M. B., Canseco, J. A., Kepler, C. K., Vaccaro, A. R., Hilibrand, A. S., et al. (2022) · Global Spine Journal · doi:10.1177/21925682221119132 · Cited by 11
Taylor, E. L., Weaver, S. R., Lorang, I. M., Arnold, K. M., Bradley, E. W., de Velasco, E. M. F., Wickman, K., & Westendorf, J. J. (2022) · Bone · doi:10.1016/j.bone.2022.116391 · Cited by 11
Prevalence of Low Bone Density and Comorbid Hypogonadism in Patients With Chronic Pancreatitis
Gupta, N., Singh, S., Vargas, L. M., Moore, T. E., Shostrom, V., & Boerner, B. P. (2019) · Pancreas · doi:10.1097/mpa.0000000000001257 · Cited by 10
The Inhibitory Effect of NSAIDs and Opioids on Spinal Fusion: An Animal Model
Lambrechts, M. J., D’Antonio, N. D., Heard, J. C., Yalla, G. R., Karamian, B. A., Markova, D., & Kepler, C. K. (2024) · Spine · doi:10.1097/brs.0000000000004959 · Cited by 10
Moradi, M., Doustimotlagh, A. H., Dehpour, A. R., Rahimi, N., & Golestani, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116706 · Cited by 9
The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism
Balodimos, S., Nikolaou, K., Njau, S., Karamouzis, M., & Kovatsi, L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1068321 · Cited by 9
Ageísmo: um estudo com grupos de Terceira Idade
Rozendo, A. D. S. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.23925/2176-901x.2016v19i3p79-89 · Cited by 9
Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids
Vellucci, R., Mattia, C., Celidonio, L., & Mediati, R. D. (2016) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2016.13.2.089 · Cited by 8
Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management
Barrière, D. A., Midavaine, É., Doré-Savard, L., Kirby, K., Tremblay, L., Beaudoin, J.-F., Beaudet, N., Longpré, J., Lecomte, R., Lepage, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56622-5 · Cited by 8
Effect of Naloxone Hydrochloride on Osteogenesis in Chick Embryos
Лисков, А. В., Solnyshkova, T. G., Фролов, Б. А., & Павловичев, С. А. (2005) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-005-0286-2 · Cited by 8
Abou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Carvalho, A. L., Brooks, D. J., Barlow, D., Langlais, A. L., Morrill, B., Houseknecht, K. L., Bouxsein, M. L., Lian, J. B., King, T., Farina, N. H., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4690 · Cited by 7
Moussalem, C. K., Ftouni, L., Abou-Mrad, Z., Bsat, S. A., Houshiemy, M. N. E., Alomari, S. O., & Omeis, I. A. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106799 · Cited by 7
Heroin induced osteopenia: a cause of bilateral insufficiency femoral neck fracture in a young adult
Lazarides, S., Varghese, D., & Nanu, A. M. (2005) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-005-0253-7 · Cited by 7
Opioid-induced biochemical alterations of the neuroendocrine axis
Thosani, S., & Jiménez, C. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.55 · Cited by 6
Orthodontic tooth movement in cholestatic and cirrhotic rats
Shirazi, M., Ameri, A., Shafaroodi, H., Motahhary, P., Saleh, T., Ghasemi, M., & Dehpour, A. R. (2008) · Journal of Orthodontics · doi:10.1179/146531207225022536 · Cited by 6
Ji, C., Liu, B., Shao, Y., Liang, T., Jiang, H., Chen, G., & Luo, Z. (2020) · Bioscience Reports · doi:10.1042/bsr20194207 · Cited by 6
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology
Puri, C., Dannenberg, C., Ucci, A., Ponzetti, M., Pucci, E., Silvestri, L., Lau, P., Frings‐Meuthen, P., Heer, M. A., Rucci, N., et al. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01199-z · Cited by 5
Relation between Bone Mass and Catecholamines in the General Population
Martín-Escudero, J. C., Pérez‐Castrillón, J. L., Blanco, F. S., Mouronte, D. A., Bellido‐Casado, J., & Martín, J. M. (2007) · Hormone Research in Paediatrics · doi:10.1159/000099469 · Cited by 5
Self-citationPereira, D. E., Smadi, Z., Bhat, S., McComis, E. M., & Hosseinzadeh, P. (2025) · Injury · doi:10.1016/j.injury.2025.112926 · Cited by 4
Swiggett, S. J., Ciminero, M. L., Weisberg, M. D., Vakharia, R. M., Sadeghpour, R., & Choueka, J. (2021) · Shoulder & Elbow · doi:10.1177/1758573221994790 · Cited by 4
Gartenberg, A., Petrie, A., Yen, W. W., & Cho, W. (2024) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2024.062 · Cited by 4
Shih, Y.-J., Chang, W., & Yang, S. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06377-y · Cited by 4
Vasilyev, A. V., Bukharova, T. B., Volkov, A. V., Вихрова, Е. Б., Bolshakova, G. B., & Goldstein, D. V. (2014) · Genes and Cells · doi:10.23868/gc120391 · Cited by 4
Lee, C. W., Muo, C., Liang, J., Chang, S.-N., Chang, Y.-J., & Kao, C. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2331-8 · Cited by 3
Assessing the Relationship between Opioid Therapy and Osteoporosis
Ali, K., Blake, N., & Ahmed, N. (2024) · International journal of Pain · doi:10.56718/ijp.24-015 · Cited by 3
Impact of Long-Term Opioid Use on Bone Health
Kapoor, A. K., Rana, A., & Bhothra, M. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24aug1485 · Cited by 3
Rare and Serious Side Effects in Chronic Pain after Opioids
Bajwa, S. S. (2012) · Journal of Pain & Relief · doi:10.4172/2167-0846.1000106 · Cited by 3
Sindt, J. E., & Jenkinson, R. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00018-1 · Cited by 3
Hioki, T., Tokuda, H., Tanabe, K., Kim, W., Tachi, J., Yamaguchi, S., Matsushima-Nishiwaki, R., Kozawa, O., & Iida, H. (2021) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102323 · Cited by 2
Conservative Treatments of Osteochondral Lesions of the Knee
Morales, M., & Irlandini, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82958-2_34 · Cited by 2
Predictors of Opioid Resistance: An Investigation in Cancer Pain
Ogawa, Y., Kurihara, T., Sakurai, M., Momma, M., Nakayama, H., Higuchi, H., Kogo, M., & Kiuchi, Y. (2022) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2022.2064033 · Cited by 2
Metzger, C. E., Grecco, G. G., Tak, L. Y., Atwood, B. K., & Allen, M. R. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01239-8 · Cited by 2
Olmos, J. M., Amado, J. A., Valero, C., Hernández, J. L., & González-Macías, J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02457.x · Cited by 2
Self-citationFate of Mu Receptors During Rat Skeletogenesis
Cooney, T. E., Konieczko, E. M., Roach, L., & Poole, B. (2009) · Orthopedics · doi:10.3928/01477447-20090201-19 · Cited by 2
Osteoporosis e infección por el virus de la inmunodeficiencia humana
Olmos, J. M., & González-Macías, J. (2007) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/s1577-3566(07)75615-4 · Cited by 1
Self-citationDisminución de la masa ósea en pacientes con infección por el virus de la inmunodeficiencia humana
Olmos, J. M., & González-Macías, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)72693-4 · Cited by 1
Self-citationCan Minocycline Reduce Cytokine-Induced Bone Resorption After SCI?
Gong, Y. (2015) · OakTrust (Texas A&M University Libraries) · Cited by 1
Bone Marker and Immunohistochemistry Changes in Toxic Environments
Shuid, A. N., Mohamed, I. N., Muhammad, N., Ramli, E. S. M., & Mohamed, N. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1516-3_10
Opioid Controversies in Chronic Non Cancer Pain
Veiga, D., & Romão, J. (2016) · Journal of Anesthesia & Clinical Research · doi:10.4172/2155-6148.1000592
Bone Fractures in Patients Using Tapentadol or Oxycodone: An Exploratory US Claims Database Study
Morlion, B. J., Margarit, C., Wild, I., Karra, R., Liedgens, H., Sohns, M., & Finco, G. (2020) · Pain Management · doi:10.2217/pmt-2020-0065
The effects of maternal and paternal exposure to tramadol on rat prenatal foetuses
El-Balshy, R., Zowail, M. E., Nafie, E. H., & Abou-Bakr, S. H. (2021) · International Journal of Biological Research · doi:10.14419/ijbr.v9i1.31558
(2008) · CRC Press eBooks · doi:10.1201/9780849378812.ch5
Nonoperative Pharmacological and Biologic Strategies for Osteoarthritis
Montagna, A., Herman, K., & Gobbi, A. W. (2024) · Springer eBooks · doi:10.1007/978-3-030-65430-6_56-1
Opioid-induced Endocrinopathies - A Narrative Review
Khalil, A., & Kalhan, A. (2025) · Academic Medicine & Surgery · doi:10.62186/001c.147430
Melemedjian, O. K. (2007) · UA Campus Repository (The University of Arizona)
Additional file 1 of Effects of maternal consumption of morphine on rat skeletal system development
Saeidinezhad, M., Razban, V., Safizadeh, H., & Ezzatabadipour, M. (2021) · Figshare · doi:10.6084/m9.figshare.14594288
Metadata
- Authors
- Pérez-Castrillón, J. L., Olmos, J. M., Gómez, J. J., Barrallo, A., Riancho, J. A., Perera, L., Valero, C., Amado, J. A., & González-Macías, J.
- Affiliations
- Universidad de Cantabria (ES)
- Universidad de Salamanca (ES)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 72
- Issue
- 3
- Pages
- 187-194
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2012186884
- Semantic Scholar
- 9d98b4bb3faf293a1ac066dbb2a48d51917f7482
- Cited by
- 99
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 0.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society for Bone and Mineral Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- opioid receptors, osteoblast-like cells, MG-63 cells, osteocalcin secretion, alkaline phosphatase, morphine, enkephalin, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, naloxone, endogenous opioids, stress response, bone formation, osteoporosis
- MeSH terms
- Alkaline Phosphatase, Cell Survival, Cells, Cultured, Humans, Levallorphan, Morphine, Opioid-Related Disorders, Neurons, Osteoblasts, Receptors, Opioid, RNA, Messenger, Spinal Cord, Steroid Hydroxylases, Stress, Physiological, Vitamin D, Osteocalcin, Opioid Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.